APGE

NASDAQ · Biotechnology

Apogee Therapeutics Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$135.07

-0.01 (-0.01%)

As of Sep 23, 8:20 PM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 6 29%

Hold 15 71%

Sell 0 0%

Price Target

Analyst Price Target -24.8% upside

Low Target $78.76

Average Target $101.57

High Target $153.22

Current Price $135.07

Current
$135.07

Target
$101.57

$78.76 $101.57 avg $153.22

Scenario Analysis

Bear Case

$78.76

-41.7%

Low target

Base Case

$101.57

-24.8%

Avg target

Bull Case

$153.22

+13.4%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$135.09

0.0% from high

52-Week Low

$35.39

+281.7% from low

50-Day SMA

$73.88

+82.8% vs SMA

200-Day SMA

$52.13

+159.1% vs SMA

RSI (14)

48.1

Neutral

Target vs 52W High

$101.57

-24.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%